Loading organizations...
Loading organizations...
Biopharmaceutical company developing novel nucleic acid medications.
Arnatar Therapeutics has raised $52.0M across 1 funding round.
Arnatar Therapeutics has raised $52.0M in total across 1 funding round.
Arnatar Therapeutics has raised $52.0M in total across 1 funding round.
Arnatar Therapeutics's investors include 3E Bioventures Capital, Eight Roads Ventures, Chuanhua Capital, F-Prime Capital, Gaorong Capital, Hongsheng Capital, New Alliance Capital, Yijing Capital.
Arnatar Therapeutics has raised $52.0M across 1 funding round. Most recently, it raised $52.0M Series A in August 2025.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Aug 25, 2025 | $52.0M Series A | 3E Bioventures Capital, Eight Roads Ventures | Chuanhua Capital, F-Prime Capital, Gaorong Capital, Hongsheng Capital, New Alliance Capital, Yijing Capital |